• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cells . Identification of Cellular Factors Required for SARS-CoV-2 Replication

tetano

Editor, Senior Moderator
Cells


. 2021 Nov 13;10(11):3159.
doi: 10.3390/cells10113159.
Identification of Cellular Factors Required for SARS-CoV-2 Replication


Aleksandra Synowiec[SUP] 1 [/SUP], Malwina Jedrysik[SUP] 1 [/SUP], Wojciech Branicki[SUP] 2 [/SUP], Adrianna Klajmon[SUP] 2 [/SUP], Jing Lei[SUP] 3 [/SUP], Katarzyna Owczarek[SUP] 1 [/SUP], Chen Suo[SUP] 3 4 [/SUP], Artur Szczepanski[SUP] 1 5 [/SUP], Jingru Wang[SUP] 3 [/SUP], Pengyan Zhang[SUP] 3 [/SUP], Pawel P Labaj[SUP] 6 [/SUP], Krzysztof Pyrc[SUP] 1 [/SUP]



Affiliations

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the recently emerged virus responsible for the COVID-19 pandemic. Clinical presentation can range from asymptomatic disease and mild respiratory tract infection to severe disease with lung injury, multiorgan failure, and death. SARS-CoV-2 is the third animal coronavirus to emerge in humans in the 21st century, and coronaviruses appear to possess a unique ability to cross borders between species and infect a wide range of organisms. This is somewhat surprising as, except for the requirement of host cell receptors, cell-pathogen interactions are usually species-specific. Insights into these host-virus interactions will provide a deeper understanding of the process of SARS-CoV-2 infection and provide a means for the design and development of antiviral agents. In this study, we describe a complex analysis of SARS-CoV-2 infection using a genome-wide CRISPR-Cas9 knock-out system in HeLa cells overexpressing entry receptor angiotensin-converting enzyme 2 (ACE2). This platform allows for the identification of factors required for viral replication. This study was designed to include a high number of replicates (48 replicates; 16 biological repeats with 3 technical replicates each) to prevent data instability, remove sources of bias, and allow multifactorial bioinformatic analyses in order to study the resulting interaction network. The results obtained provide an interesting insight into the replication mechanisms of SARS-CoV-2.

Keywords: CRISPR-Cas9; SARS-CoV-2; cellular factors; coronavirus; mechanisms of infection; viral pathogenesis.
 
Back
Top Bottom